Praxis Precision Medicines Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Praxis Precision Medicines Inc 's ROA in the second quarter of 2026?
Praxis Precision Medicines Inc recorded a cumulative net loss of $-339 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -26.54%.

However, within the Healthcare sector 437 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 3792, from total ROA ranking in the first quarter of 2026 at 4628.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	410.88 %	204.94 %	67.31 %	-4.44 %	2.53 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-339	-327	-303	-273	-251
Return On Assets (TTM)	-26.54 %	-40.21 %	-53.51 %	-57.8 %	-52.62 %
PRAX's Total Ranking	# 3792	# 4628	# 4129	# 4126	# 4108
Total Assets (TTM) in million	2,315	1,460	938	397	453
Seq. Total Assets Change	58.56 %	55.69 %	136.23 %	-12.4 %	-5.36 %
Seq. Net Income Change	-	-	-	-	-

PRAX's 5 Years Annual ROA >> Back to PRAX Management Effectiveness >> Compare PRAX ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 169
Sector	# 438
Overall	# 3645

Return On Assets Statistics
High	Average	Low
-24.17 %	-73 %	-137.72 %
(Jun 30 2021)		(Mar 31 2023)

Financial Statements
Praxis Precision Medicines Inc 's Assets	$ 2,315 million	PRAX's Balance sheet
Praxis Precision Medicines Inc 's Income	$ -84 million	Quarterly PRAX's Income Statement
PRAX's Income by Division		See PRAX's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	161.51 %	459.24 %	-24.69 %	-60.36 %	-4.47 %
Total Assets in million	1,265	484	86	115	290
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-303	-183	-123	-214	-167
Annual Return On Assets	-23.98 %	-37.81 %	-142.57 %	-186.42 %	-57.68 %

PRAX's 5 Years Annual ROA >> Back to PRAX Management Effectiveness >> Compare PRAX ROA to its Competitors

More Return On Assets Ratios
PRAX's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
PRAX's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for PRAX's Competitors
Subscribers only: Roa for Praxis Precision Medicines Inc 's Suppliers
Subscribers only: Return On Assets for PRAX's Customers

You may also want to know
PRAX's Roi	PRAX's Inventory Turnover Ratio	PRAX's Growth Rates	PRAX's Dividend Comparisons
	PRAX's Profitability Ratios	PRAX's Asset Turnover Ratio	PRAX's Dividend Growth
PRAX's Roe	PRAX's Valuation Ratios	PRAX's Financial Strength Ratios	PRAX's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector

ROA

Date modified: 2026-09-05T15:26:29+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.